Market Overview

CVS Will Acquire Target's Pharmacy Business For Nearly $2 Billion

Share:
CVS Will Acquire Target's Pharmacy Business For Nearly $2 Billion
Related CVS
Easter Might Be The New Christmas For Some Companies
What Makes Mylan's Newest EpiPen Lawsuit Different?
The Bulls Are Back: These 4 Leaders' Earnings Could Keep Stocks Running (Investor's Business Daily)
Related TGT
Domestic Fair Trade Label Set To Enrich Local Economies, Expand Retailer Options
Benzinga's Bulls And Bears For The Week: Starbucks, Tesla, United And More

CVS Health Corp (NYSE: CVS) has signed an agreement alongside Target Corporation (NYSE: TGT).

CVS will acquire and rebrand Target’s pharmacies and clinics and will operate them in a different way, according to a press release filed on Monday morning. Shares of both companies are up slightly in pre-market trading.

The deal, in particular, will cost CVS $1.9 billion but will add more than 1,660 pharmacies in 47 states. CVS will operate the pharmacies “through a store-within-a-store format.”

Related Link: Big Biotech Stocks See Declining Short Interest

CVS Pharmacy will be included in Target’s new stores that offer pharmacy services.

The two companies plan to build five to 10 flexible format stores in the next two years -- the new stores will be named TargetExpress and will include the CVS Pharmacy brand.

The transaction will allow CVS to reach out to new and potential patients, add a new retail channel, and expand its convenience. Larry Merlo, CVS Health President and CEO suggested "this strategic relationship with Target supports the highly complementary customer base, brand and culture we share."

Brian Cornell, Target’s CEO and Chairman, added, "By partnering with CVS Health, we will offer our guests industry leading health care services, and at the same time, sharpen our focus on elevating the way we deliver wellness products and experiences to our guests."

Posted-In: CVS CVS Target Target Target PharmacyNews Events Best of Benzinga

 

Related Articles (CVS + TGT)

View Comments and Join the Discussion!